| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |